Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

The Genetic, Pharmacogenomic, and Immune Landscapes Associated with Protein Expression across Human Cancers.

Cancer research - 15 Nov 2023

Chen Chengxuan, Liu Yuan, Li Qiang, Zhang Zhao, Luo Mei, Liu Yaoming, Han Leng

Abstract excerpt

Proteomics is a powerful approach that can rapidly enhance our understanding of cancer development. Detailed characterization of the genetic, pharmacogenomic, and immune landscape in relation to protein expression in patients with cancer could provide new insights into the functional roles of proteins in cancer. By taking advantage of the genotype data from The Cancer Genome Atlas and protein expression data from...

Topics

Humans
Proteomics
Pharmacogenetics
Proteome
Genotype
Neoplasms
Tumor Microenvironment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37548539
DOI: 10.1158/0008-5472.CAN-23-0758
PMCID: PMC10843800

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Genetic, Pharmacogenomic, and Immune Landscapes Associated with Protein Expression across Human Cancers.PMID 37548539Read ↗

Pan-cancer proteogenomics expands the landscape of therapeutic targetsSemantic proximity Read ↗

Integrated Genomic Characterization of the Human Immunome in Cancer.Semantic proximity Read ↗

Comprehensive and Integrated Genomic Characterization of Human Immunome in CancerSemantic proximity Read ↗

Pan-cancer mapping of differential protein-protein interactions.Semantic proximity Read ↗

Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.Semantic proximity Read ↗

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma.Semantic proximity Read ↗

PancanQTLv2.0: a comprehensive resource for expression quantitative trait loci across human cancers.Semantic proximity Read ↗

Master regulators governing protein abundance across ten human cancer typesSemantic proximity Read ↗

A Pan-Cancer Immunogenomic Atlas for Immune Checkpoint Blockade ImmunotherapySemantic proximity Read ↗

A Novel Patient-specific Protein Expression-based Algorithmic Model for Immune Checkpoint Inhibition Therapy Response Prediction in a Pan-cancer CohortSemantic proximity Read ↗

Combinations of genomic alterations and immune microenvironmental features associate with patient survival in multiple cancer typesSemantic proximity Read ↗

Identifying proteomic risk factors for cancer using prospective and exome analyses: 1,463 circulating proteins and risk of 19 cancers in the UK BiobankSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.